Autocrine Regulation of Macrophage Activation Via Exocytosis of ATP and Activation of P2Y11 Receptor

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Apr 12

PMID 23577075

Citations 61

Authors

Hayato Sakaki

Mitsutoshi Tsukimoto

Hitoshi Harada

Yoshinori Moriyama

Shuji Kojima

Affiliations

Soon will be listed here.

Abstract

It is important to understand the mechanisms that regulate macrophage activation to establish novel therapies for inflammatory diseases, such as sepsis; a systemic inflammatory response syndrome generally caused by bacterial lipopolysaccharide (LPS). In this study, we investigated the involvement of extracellular ATP-mediated autocrine signaling in LPS-induced macrophage activation. We show here that ATP release via exocytosis, followed by activation of P2Y11 receptor, is a major pathway of the macrophage activation, leading to release of cytokines. Treatment of human monocyte THP-1 cells with LPS induced rapid ATP release from cells, and this release was blocked by knockdown of SLC17A9 (vesicular nucleotide transporter, VNUT), which is responsible for exocytosis of ATP. ATP-enriched vesicles were found in cytosol of THP-1 cells. These data suggest the involvement of vesicular exocytosis in the release of ATP. Knockdown of SLC17A9, the P2Y11 antagonist NF157 or knockdown of P2Y11 receptor significantly suppressed both M1-type polarization and IL-6 production in THP-1 cells, indicating an important role of activation of P2Y11 receptor by released ATP in macrophage activation. Next, the effect of NF157 on LPS-induced immune activation was examined in vivo. Administration of LPS to mice caused increase of serum IL-1ß, IL-6, IL-12 and TNF-alpha levels at 3-24 h after the administration. Pre-treatment of LPS-treated mice with NF157 suppressed both elevation of proinflammatory cytokines in serum and M1 polarization of peritoneal/spleen macrophages. Moreover, post-treatment with NF157 at 30 min after administration of LPS also suppressed the elevation of serum cytokines levels. We conclude that vesicular exocytosis of ATP and autocrine, positive feedback through P2Y11 receptors is required for the effective activation of macrophages. Consequently, P2Y11 receptor antagonists may be drug candidates for treatment of inflammatory diseases such as sepsis.

Citing Articles

Deficiency of P2RY11 causes narcolepsy and attenuates the recruitment of neutrophils and macrophages in the inflammatory response in zebrafish.

Zhao L, Wang L, Wang Y, Liu A, Xiao Q, Hu M Cell Biol Toxicol. 2024; 40(1):36.

PMID: 38771396 PMC: 11108927. DOI: 10.1007/s10565-024-09882-5.

DAMPs and radiation injury.

Yamaga S, Aziz M, Murao A, Brenner M, Wang P Front Immunol. 2024; 15:1353990.

PMID: 38333215 PMC: 10850293. DOI: 10.3389/fimmu.2024.1353990.

A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples.

Hiefner J, Rische J, Bunders M, Worthmann A Front Immunol. 2023; 14:1250762.

PMID: 37799723 PMC: 10548204. DOI: 10.3389/fimmu.2023.1250762.

Purinergic signaling via P2X receptors and mechanisms of unregulated ATP release in the outer retina and age-related macular degeneration.

Molcak H, Jiang K, Campbell C, Matsubara J Front Neurosci. 2023; 17:1216489.

PMID: 37496736 PMC: 10366617. DOI: 10.3389/fnins.2023.1216489.

An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential.

Cao Y, Chen E, Wang X, Song J, Zhang H, Chen X Cancer Cell Int. 2023; 23(1):20.

PMID: 36750864 PMC: 9903449. DOI: 10.1186/s12935-023-02859-0.

References

Talasila A, Germack R, Dickenson J . Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts. Br J Pharmacol. 2009; 158(1):339-53. PMC: 2795244. DOI: 10.1111/j.1476-5381.2009.00172.x. View

Schenk U, Westendorf A, Radaelli E, Casati A, Ferro M, Fumagalli M . Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal. 2008; 1(39):ra6. DOI: 10.1126/scisignal.1160583. View

Sperlagh B, Hasko G, Nemeth Z, Vizi E . ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int. 1998; 33(3):209-15. DOI: 10.1016/s0197-0186(98)00025-4. View

Grahames C, Michel A, Chessell I, Humphrey P . Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol. 1999; 127(8):1915-21. PMC: 1566177. DOI: 10.1038/sj.bjp.0702732. View

Cohen J . The immunopathogenesis of sepsis. Nature. 2002; 420(6917):885-91. DOI: 10.1038/nature01326. View

Sathe M, Woo K, Kresge C, Bugde A, Luby-Phelps K, Lewis M . Regulation of purinergic signaling in biliary epithelial cells by exocytosis of SLC17A9-dependent ATP-enriched vesicles. J Biol Chem. 2011; 286(28):25363-76. PMC: 3137107. DOI: 10.1074/jbc.M111.232868. View

Pelegrin P, Surprenant A . Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 2009; 28(14):2114-27. PMC: 2699392. DOI: 10.1038/emboj.2009.163. View

Hara S, Mizukami H, Kuriiwa F, Mukai T . cAMP production mediated through P2Y(11)-like receptors in rat striatum due to severe, but not moderate, carbon monoxide poisoning. Toxicology. 2011; 288(1-3):49-55. DOI: 10.1016/j.tox.2011.07.001. View

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

10.

Gordon S . The macrophage: past, present and future. Eur J Immunol. 2007; 37 Suppl 1:S9-17. DOI: 10.1002/eji.200737638. View

11.

Hotchkiss R, Karl I . The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348(2):138-50. DOI: 10.1056/NEJMra021333. View

12.

Stein M, Keshav S, Harris N, Gordon S . Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992; 176(1):287-92. PMC: 2119288. DOI: 10.1084/jem.176.1.287. View

13.

Sutterwala F, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger G, Grant E . Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006; 24(3):317-27. DOI: 10.1016/j.immuni.2006.02.004. View

14.

Bozza F, Salluh J, Japiassu A, Soares M, Assis E, Gomes R . Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007; 11(2):R49. PMC: 2206478. DOI: 10.1186/cc5783. View

15.

Yu J, Sheung N, Soliman E, Spirli C, Dranoff J . Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP. Am J Physiol Gastrointest Liver Physiol. 2009; 296(3):G563-71. PMC: 2660176. DOI: 10.1152/ajpgi.90502.2008. View

16.

Barbera-Cremades M, Baroja-Mazo A, Gomez A, Machado F, Di Virgilio F, Pelegrin P . P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release. FASEB J. 2012; 26(7):2951-62. DOI: 10.1096/fj.12-205765. View

17.

Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A . ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A. 2008; 105(23):8067-72. PMC: 2430360. DOI: 10.1073/pnas.0709684105. View

18.

Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View

19.

Martinez F, Helming L, Gordon S . Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2008; 27:451-83. DOI: 10.1146/annurev.immunol.021908.132532. View

20.

Kilbourn R, Griffith O, Gross S . Pathogenetic mechanisms of septic shock. N Engl J Med. 1993; 329(19):1427-8. DOI: 10.1056/NEJM199311043291916. View